A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia.
about
The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia TherapyBET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD.The Globalization of Cooperative Groups.Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemiamiR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype.MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia.The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment.Stem cell-directed therapies in pancreatic cancer.Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design.The Interplay between PP2A and microRNAs in Leukemia.MicroRNAs in Myeloid Hematological Malignancies.CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemiamiR-99 regulates normal and malignant hematopoietic stem cell self-renewal.miR-146 and miR-155: Two Key Modulators of Immune Response and Tumor Development.Cancer Stem Cells.Biological Aspects of mTOR in LeukemiaElevated PTPN2 expression is associated with inferior molecular response in de-novo chronic myeloid leukaemia patients
P2860
Q26799596-90BA1A59-6FC3-4FA4-863F-FF81943BB550Q34289202-AFFE0F50-D83F-442A-B1AA-D38D0E2F6C07Q36119749-AC15510C-0237-453A-A0A5-76557704E9F4Q36248867-AC4EFF8B-9702-430C-B8C0-A6640A7F5E1DQ36568466-D395C0EA-5F66-4105-BA12-EEBA55821520Q36629521-0740BC53-7DF7-4488-87AD-1373EE329C71Q36882358-B6BF6028-4B87-4004-A761-EB5191895C8AQ37727786-C1BC3038-DAC9-4BFF-9E26-D0EEEA78283CQ38170621-82F96A49-D5DC-4C22-B966-11131C28E911Q38253011-F15D9C50-7647-436B-92D9-1EAD2669F713Q38370368-D2FF585B-B3C0-4584-B85D-970FCED9C884Q38599595-0030DE29-0154-469D-8C5C-CB5BB0FD05D6Q42323497-DA137735-70BF-4105-9996-AA5911B16874Q48364240-97AA5E21-EBF7-4A7E-8A56-E2C7DAE5A358Q52587340-A2AF9F2B-CBF9-4615-BC5C-31D2BEADFF6FQ53040917-7B1E31CB-694D-4898-8E5D-97A9142E9F1FQ58780065-50C2DD56-1851-47CE-961D-2160CDE50BB1Q59236451-B04C75B6-F4F9-4DA6-811D-AD2B626F95AC
P2860
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A stem cell-like gene expressi ...... normal acute myeloid leukemia.
@en
A stem cell-like gene expressi ...... normal acute myeloid leukemia.
@nl
type
label
A stem cell-like gene expressi ...... normal acute myeloid leukemia.
@en
A stem cell-like gene expressi ...... normal acute myeloid leukemia.
@nl
prefLabel
A stem cell-like gene expressi ...... normal acute myeloid leukemia.
@en
A stem cell-like gene expressi ...... normal acute myeloid leukemia.
@nl
P2093
P2860
P50
P356
P1433
P1476
A stem cell-like gene expressi ...... normal acute myeloid leukemia.
@en
P2093
A J Carroll
A-K Eisfeld
B L Powell
G Marcucci
J E Kolitz
J Kohlschmidt
K H Metzeler
P2860
P2888
P304
P356
10.1038/LEU.2013.181
P577
2013-06-14T00:00:00Z